Pay in 4 interest-free payments of $5.34 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Intravenous injections (IV): Rare, rapid absorption, requires professional administration
Quality assessment shows Janoshik COA documentation claiming 98-99% purity comparable to competitor testing, with user experiences suggesting 85-90% satisfaction rates and moderate batch consistency matching typical mid-tier vendor performance rather than demonstrating superior quality justifying premium pricing
Research Use Only Not for human consumption or medical applications
Some benefits may be subtle, and formal cognitive assessments can be helpful in tracking progress
US$ 28.64
US$ 27.47
US$ 28.57
US$ 22.72
US$ 20.04
US$ 22.13
